EV/EBITDA:
-34.95-2.65(-8.20%)Summary
- As of today, TARS EV/EBITDA is -34.95, with a fall of -2.65 (-8.20%) during the most recent trading session on October 15, 2025.
- Over the past year, TARS EV/EBITDA has dropped by -25.57 (-272.60%).
- TARS EV/EBITDA is now -1613.24% below its all-time high of -2.04.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -8.2% | +8.2% | +7.3% |
| 1M1 Month | -56.3% | +56.3% | +48.1% |
| 3M3 Months | -97.6% | +97.6% | +80.4% |
| 6M6 Months | -90.8% | +64.2% | +51.8% |
| YTDYTD | -96.1% | +49.9% | +35.4% |
| 1Y1 Year | -272.6% | +139.7% | +99.4% |
| 5Y5 Years | -85.9% | +818.6% | +264.2% |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -21.84 | -60.0% | -34.95 | at low |
| 3M | 3-Month | -16.28 | -114.7% | -34.95 | at low |
| 6M | 6-Month | -13.91 | -151.3% | -34.95 | at low |
| 1Y | 1-Year | -9.04 | -286.6% | -34.95 | at low |
| 3Y | 3-Year | -2.04 | -1613.2% | -34.95 | at low |
| 5Y | 5-Year | -2.04 | -1613.2% | -126.17 | +72.3% |
| All-Time | All-Time | -2.04 | -1613.2% | -126.17 | +72.3% |
TARS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -34.95(-96.1%) |
| 2024 | -17.82(-372.7%) |
| 2023 | -3.77(-15.3%) |
| Date | Value |
|---|---|
| 2022 | -3.27(+86.1%) |
| 2021 | -23.56(+5.8%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of TARS is -34.95
What is the all-time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high EV/EBITDA is -2.04
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals, Inc. EV/EBITDA has changed by -17.13 (-96.13%) since the beginning of the year
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -25.57 (-272.60%)